重组人性化原17型通过抗炎作用促进口腔愈,加速组织愈合
Yukai Hao1, Baoling Zhao1, Dongchao Wu1
1Department of Endodontics, Shanxi Province Key Laboratory of Oral Diseases Prevention and New Materials, Shanxi Medical University School and Hospital of Stomatology, Taiyuan, 030001, People's Republic of China.
Journal of inflammation research
|July 29, 2024
概括
复合人性化原17型 (rhCol 17) 通过减少炎症和加速大鼠组织修复,有效促进口腔的愈合. 这种新的生物材料显示出治疗复发性口腔的前景.
科学领域:
- 生物材料科学 生物材料科学
- 组织工程是组织工程.
- 口腔医学是指口腔医学.
背景情况:
- 重组人性化原蛋白 (rhCol) 是一种具有抗炎和组织愈合特性的新型生物材料.
- 再组合人性化原17型 (rhCol 17) 在口腔愈的特定作用需要进一步研究.
研究的目的:
- 研究rhCol 17对人类牙纤维细胞 (HGF) 增殖和炎症的影响.
- 通过评估其抗炎和组织愈合能力,评估rhCol 17在促进大鼠模型口腔愈的有效性.
主要方法:
- 在体外研究中评估了rhCol 17对高基因增殖 (CCK8试验) 和由脂多糖 (LPS) 诱导的炎症的影响.
- 一个体内研究涉及Sprague-Dawley大鼠诱导口腔,每天用碳素或含有碳素的rhCol 17进行治疗.
- 组织学染色和PCR分析是在治疗后的第3天和第5天收集的组织样本上进行的.
主要成果:
- rhCol 17表现出良好的生物相容性,促进HGF的增殖和迁移,同时减少细胞炎症.
- 在体内,rhCol 17显著降低了炎症,增强了原沉积,并促进了部位的血管生成.
- 这些发现表明,rhCol 17有效地加速了老鼠的口腔愈.
结论:
- rhCol 17具有显著的抗炎作用,并加速组织愈合.
- 含有 rhCol 17 的原体喷雾剂代表了对复发性口腔的潜在新疗法.
更多相关视频
08:43Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model
Published on: February 7, 2018
7.6K
05:48Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion
Published on: March 18, 2014
9.8K
相关概念视频
Phases of Wound Repair
5.9K
Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
5.9K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
